October 6, 2022 12:00 PM SGT

Genome editing: Disease modelling to novel therapeutics

Speakers

Abstract
Date:  October 6, 2022
Time: 9:30am IST, 12:00pm SGT, 1:00pm JST, KST, 3:00pm AEST, 5:00 NZST
 
Genome editing is—or will soon be—in the clinic for several diseases and more applications are currently under development. The rapid pace of the field, spurred by the transformative CRISPR technology, demands constant updates to our scientific and technical skillsets to stay relevant.
 
Gibco Galaxy Tour Webinar connects you to our Gibco experts who will discuss the use of genome editing for development of next generation disease models and novel therapies. To help you take your research to the next level, we will provide an overview of how to design a genome editing experiment, share applications in stem cell disease models and discuss important considerations, such as off-target effects and GMP-grade reagents, when developing therapeutics with gene edits. 

Topics include:
  • Current approaches on genome editing in induced pluripotent stem cells (iPSC) 
  • Application of genome editing in the generation of cardiac disease models
  • Design of genome editing experiment
  • Application of GMP-manufactured Cas9 in primary T-cell workflow
  • Minimizing off target risks with high fidelity Cas9 protein  
 
Learning Objectives:
  • You will be learning or revisiting new tools and techniques to design a genome editing experiment with iPSC for disease model generation
  • You will also learn about the need for GMP-grade reagents, high-fidelity Cas9 protein and integrated genome editing workflow solutions to facilitate clinical and commercial scale manufacturing of T cells therapeutics 

 

 
Webinars will be available for unlimited on-demand viewing after live event.
 

Show Resources
You May Also Like
NOV 01, 2022 10:00 AM PDT
NOV 01, 2022 10:00 AM PDT
Date: November 01, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 6:00pm (CET) Our laboratory developed the Pig-a gene mutation assay as a means to simply and reliably evaluate the potential mutage...
NOV 16, 2022 7:00 PM PST
C.E. CREDITS
NOV 16, 2022 7:00 PM PST
Date: November 16, 2022 Time: 2:00pm (AEST) Date: November 17, 2022 7:00pm (PST), 10:00pm (EST), 4:00am (CET) The growth in FDA-approved cell and gene therapy products for the treatment of d...
SEP 22, 2022 9:00 AM PDT
SEP 22, 2022 9:00 AM PDT
Date: September 22, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Optimizing platforms for surgical specimen collection and deep human phenotyping was used to enhance protein biomarke...
OCT 13, 2022 9:00 AM +08
OCT 13, 2022 9:00 AM +08
First Broadcast: Date: October 12, 2022 Time: 8:00am PDT, 11:00am EDT Second Broadcast: Date: October 12, 2022 Time: 9:00am SGT The new Embedded CryoSPARC Live, now fully integrated with t...
SEP 27, 2022 10:00 AM PDT
SEP 27, 2022 10:00 AM PDT
Date: September 27, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Alzheimer’s disease is the most common cause of dementia and the seventh leading cause of death in the United...
AUG 10, 2022 10:00 AM PDT
AUG 10, 2022 10:00 AM PDT
Date: August 10, 2022 Time: 10:00am PDT, 1:00pm EDT The global pandemic has increased focus and scrutiny on molecular diagnostic assay development, resulting in a need for assays that provid...
Loading Comments...
Show Resources